Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Dec 13, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000031.pdf 0001237899-19-000031.xls
Dec 13, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000034.pdf 0001237899-19-000034.xls
Dec 13, 2019	3	Initial filing by director officer or owner of more than ten percent.	View HTML 0000930413-19-003027.pdf 0000930413-19-003027.xls
Dec 13, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000036.pdf 0001237899-19-000036.xls
Dec 13, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0000930413-19-003028.pdf 0000930413-19-003028.xls
Dec 13, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000037.pdf 0001237899-19-000037.xls
Dec 13, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000038.pdf 0001237899-19-000038.xls
Dec 09, 2019	SC 13D/A	An amendment to a SC 13D filing	View HTML 0001140361-19-022193.pdf 0001140361-19-022193.xls
Dec 02, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000027.pdf 0001237899-19-000027.xls
Nov 26, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000024.pdf 0001237899-19-000024.xls

Data provided by Kaleidoscope.

Investors & Media